FHIT and cancer: However, after the first fragile site gene was cloned and characterized as a cancer suppressor [57], it was suggested that FHIT and other fragile genes are altered in cancers due to their exquisite stress sensitivity rather than to a selective advantage imparted by loss of expression of fragile gene products [58].